Serial Number:
87875282
Mark:
P WUXI APPTEC
Status:
Registered
Status Date:
12-31-2019
Filing Date:
Registration Number:
5947250
Registration Date:
12-31-2019
Biological indicators for monitoring sterilization processes for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders healthcare and clinical applications; Chemical preparations for medical purposes, namely, chemical reagents for medical purposes; Chewing gum for medical purposes being nutritional supplements; Cultures of microorganisms for medical use; Depuratives for the body; Diagnostic preparations for medical purposes; Dietetic foods adapted for medical use; Disinfectants for hygiene purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the treatment of cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; Pharmaceutical preparations, namely, antivirals; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Reagent paper for medical or veterinary purposes
Mark Description:
The mark consists of a stylized capital letter "P", whereby the bowl of the letter "P" has two bands which overextend past the stem of the "P". To the right of the bowl of the "P" are four Chinese characters above a line; Below the line are the words "WUXI APPTEC" in stylized font, whereby the "W", "X" , "A" and "T" are all capitalized.
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
10-15-2019
Owner:
Mark Drawing Status:
Design plus Words, Letters, and/or Numbers
Abandon Date:
N/A
Business Name:
1228 EUCLID AVENUE
Correspondent Name:
